Imunonutrição no paciente oncológico cirúrgico: atualização e estado da arte
DOI:
https://doi.org/10.35454/rncm.v5n4.430Palavras-chave:
Cáncer, Desnutrición, Cirugía, InmunonutriciónResumo
A desnutrição nos pacientes com câncer submetidos a procedimentos cirúrgicos é um dos problemas nutricionais mais associado a desfechos clínicos adversos, como aumento do risco de infecções, aumento do risco de formação de fístulas, aumento dos dias de internação hospitalar, bem como aumento do risco de mortalidade. A imunonutrição (IMN) refere-se à utilização de diversos nutrientes em doses muito superiores às necessidades diárias a fim de modular a resposta do sistema imunológico do hospedeiro, o processo inflamatório e melhorar o estado nutricional dos pacientes cirúrgicos. É importante conhecer o estado atual do uso da IMN no paciente com câncer submetido à cirurgia, a fim de aplicar corretamente a terapia nutricional e reduzir os desfechos clínicos adversos, bem como aumentar a sobrevida. O objetivo desta revisão é conhecer o atual estado da arte da IMN no paciente oncológico cirúrgico para chegar em tempo hábil a recomendações na prática clínica baseadas na melhor evidência científica atualmente disponível.
Downloads
Referências
Klek S, Szybinski P, Szczepanek K. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg. 2014;38(4):803-12. doi: 10.1007/s00268-013-2323-z
Mariette C. Immunonutrition. J Visc Surg. 2015;152(1):S14-7. doi: 10.1016/S1878-7886(15)30005-9
Mizock BA. Immunonutrition and critical illness: an update. Nutrition. 2010;26(7-8):701-7. doi: 10.1016/j.nut.2009.11.010
Castillo-Martinez L, Castro-Eguiluz D, Copca-Mendoza ET, Perez-Camargo DA, Reyes-Torres CA, Avila EAD, et al. Nutritional assessment tools for the identification of malnutrition and nutritional risk associated with cancer treatment. Rev Invest Clin. 2018;70(3):121-5. doi: 10.24875/RIC.18002524
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898-913. doi: 10.1016/j.clnu.2021.02.005
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187-96. doi: 10.1016/j.clnu.2017.06.017
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36(3):623-50. doi: 10.1016/j.clnu.2017.02.013
Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery a review. JAMA Surg. 2017;152(3):292-8. doi: 10.1001/jamasurg.2016.4952
Adiamah A, Skořepa P, Weimann A, Lobo DN. The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Ann Surg. 2019;270(2):247-56. doi: 10.1097/SLA.0000000000003256
McCarthy MS, Martindale RG. Immunonutrition in critical illness: what is the role? Nutr Clin Pract. 2018;33(3):348-58. doi: 10.1002/ncp.10102
Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition. 2013;29(1):15-21. doi: 10.1016/j.nut.2012.02.014
Suchner U, Kuhn KS, Fürst P. The scientific basis of immunonutrition. Proc Nutr Soc. 2000;59(4):553-63. doi: 10.1017/s0029665100000793
Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-97. doi: 10.1056/NEJMoa1212722. Erratum in: N Engl J Med. 2013;368(19):1853
De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005;33(5):1125-35. doi: 10.1097/01.ccm.0000162680.52397.97
Heyland DK, Dhaliwal R. Role of glutamine supplementation in critical illness given the results of the REDOXS study. J Parenter Enteral Nutr. 2013;37(4):442-3. doi: 10.1177/0148607113488421
Yang T, Yan X, Cao Y, Bao T, Li G, Gu S, et al. Meta-analysis of glutamine on immune function and post-operative complications of patients with colorectal cancer. Front Nutr. 2021;8:765809. doi: 10.3389/fnut.2021.765809
Tsuei BJ, Bernard AC, Shane MD, Shirley LA, Maley ME, Boulanger BR, et al. Surgery induces human mononuclear cell arginase I expression. J Trauma. 2001;51(3):497-502. doi: 10.1097/00005373-200109000-00012
Barbul A, Rettura G, Levenson SM, See E. Wound healing and thymotropic effects of arginine: a pituitary mechanism of action. Am J Clin Nutr. 1983;37:786-94. doi: 10.1093/ajcn/37.5.786
Patel JJ, Miller KR, Rosenthal C, Rosenthal MD. when is it appropriate to use arginine in critical illness? Nutr Clin Pract. 2016;31(4):438-44. doi: 10.1177/0884533616652576
D’Ignazio A, Kabata P, Ambrosio MR, Polom K, Marano L, Spagnoli L, et al. Preoperative oral immunonutrition in gastrointestinal surgical patients: how the tumour microenvironment can be modified. Clin Nutr ESPEN. 2020;38:153-9. doi: 10.1016/j.clnesp.2020.05.012
Martin RCG, Agle S, Schlegel M, Hayat T, Scoggins CR, McMasters KM, et al. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE). Eur J Surg Oncol. 2017;43(4):772-9. doi: 10.1016/j.ejso.2017.01.002
Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr. 2010;34(4):378-86. doi: 10.1177/0148607110362692
Ginguay A, De Bandt JP, Cynober L. Indications and contraindications for infusing specific amino acids (leucine, glutamine, arginine, citrulline, and taurine) in critical illness. Curr Opin Clin Nutr Metab Care. 2016;19(2):161-9. doi: 10.1097/MCO.0000000000000255
Romo-Romo A, Reyes-Torres CA, Janka-Zires M, Almeda-Valdés P. El rol de la nutrición en la enfermedad por coronavirus 2019 (COVID-19). Rev Mex Endocrinol Metab Nutr. 2020;7:132-43. doi: 10.24875/RME.20000060
Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, et al. Lipids in the intensive care unit: recommendations from the ESPEN Expert Group. Clin Nutr. 2018;37(1):1-18. doi: 10.1016/j.clnu.2017.08.032
Calder PC. Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Proc Nutr Soc. 2018;77(1):52-72. doi: 10.1017/S0029665117003950
Fenton JI, Hord NG, Ghosh S, Gurzell EA. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot Essent Fatty Acids. 2013;89(6):379-90. doi: 10.1016/j.plefa.2013.09.011
Mauskopf JA, Candrilli SD, Chevrou-Séverac H, Ochoa JB. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012;10:136. doi: 10.1186/1477-7819-10-136
Bharadwaj S, Trivax B, Tandon P, Alkam B, Hanouneh I, Steiger E. Should perioperative immunonutrition for elective surgery be the current standard of care? Gastroenterol Rep (Oxf). 2016;4(2):87-95. doi: 10.1093/gastro/gow008
Zhang Y, Gu Y, Guo T, Li Y, Cai H. Perioperative immunonutrition for gastrointestinal cancer: a systematic review of randomized controlled trials. Surg Oncol. 2012;21(2):e87-95. doi: 10.1016/j.suronc.2012.01.002
Mauskopf JA, Candrilli SD, Chevrou-Séverac H, Ochoa JB. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012;10:136. doi: 10.1186/1477-7819-10-136
Jabłońska B, Mrowiec S. The role of immunonutrition in patients undergoing pancreaticoduodenectomy. Nutrients. 2020;12(9):2547. doi: 10.3390/nu12092547
Bermúdez C, Sanabria Á, Ayala J, Becerra A, Chona M, Colpas L, et al. Inmunonutrición perioperatoria. Consenso de la Asociación Colombiana de Nutrición Clínica. Rev Nutr Clín Metabol. 2019;2(1):15-28. doi: 10.35454/rncm.v2n1.055
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Carlos Reyes-Torres, Ana Daniela Delgado-Salgado, Sergio Díaz-Paredes, Eva Lucía Willars-Inman
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
